Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Oscar Health ( (OSCR) ).
Oscar Health reaffirmed its full-year 2026 financial guidance ahead of its participation in the Medicarians 2026 conference on April 21, 2026, signaling management’s confidence in its previously outlined outlook. The company also confirmed it would report first-quarter 2026 results before the market opens on May 6, 2026, followed by an earnings call, events that investors will watch for updates on performance and strategic execution.
On April 21, 2026, Oscar announced that independent director Siddhartha Sankaran will become Chair of the Board effective June 4, 2026, succeeding long-time chair Jeffery Boyd, who will not stand for reelection. The leadership transition brings a seasoned insurance executive with more than two decades of industry experience into the board’s top role, reinforcing Oscar’s governance as it pursues growth in the individual market and enters what executives describe as a pivotal phase for the business.
Boyd, who has guided Oscar through its IPO and a key period of expansion over 12 years, said the company is well positioned for strong 2026 performance and long-term growth as he steps down. Sankaran highlighted Oscar’s role in reshaping healthcare toward a more consumer-driven, efficient model, underscoring the board’s focus on leveraging the company’s technology platform to capitalize on opportunities in the individual market.
The most recent analyst rating on (OSCR) stock is a Hold with a $16.00 price target. To see the full list of analyst forecasts on Oscar Health stock, see the OSCR Stock Forecast page.
Spark’s Take on OSCR Stock
According to Spark, TipRanks’ AI Analyst, OSCR is a Neutral.
The score is driven primarily by strong recent operating/free cash flow and constructive 2026 profitability guidance. These positives are tempered by inconsistent GAAP profitability (2025 loss), ongoing risk-adjustment and membership churn uncertainty, and a weak-to-neutral technical setup with the stock still below key moving averages.
To see Spark’s full report on OSCR stock, click here.
More about Oscar Health
Oscar Health, Inc. is a healthcare technology company that operates a full-stack platform focused on improving member experience in the U.S. health insurance market. The company makes high-quality, affordable care more accessible through Individual & Family plans, Individual Coverage Health Reimbursement Arrangement (ICHRA) solutions, its +Oscar technology services, and the Lucie Health Marketplace.
Oscar targets consumers and businesses in the individual market, emphasizing simple, personal, and consumer-driven healthcare. Its offerings aim to increase choice, deepen engagement, and connect members to high-value clinical care, positioning the company as a tech-enabled insurer in a competitive and highly regulated industry.
Average Trading Volume: 7,647,357
Technical Sentiment Signal: Strong Buy
Current Market Cap: $4.64B
Learn more about OSCR stock on TipRanks’ Stock Analysis page.